Track topics on Twitter Track topics that are important to you
VANCOUVER, British Columbia, June 6, 2017 /PRNewswire/ -- Researchers have recently confirmed that virtual reality headsets tend to cause a form of motion sickness known as VR sickness, which induces nausea and vomiting. While developmental teams have tried to combat this issue, its prevalence remains common. Many in the industry fear that this will be a major obstacle for virtual reality to be adopted to the general public.
WAT Med attended LifeSciences BC's Health Networking event on May 17th and had the pleasure to meet Dr. Robert DiRaddo, the Section Head of Simulation and Digital Health at the National Research Council of Canada (NRC). Dr. DiRaddo's team develops mathematically-based interactive virtual reality and artificial intelligence technology for a wide range of uses, including neurosurgical training for surgeons, flying training for pilots, and anxiety control for airplane passengers.
Dr. DiRaddo expressed his interest in WAT Med's leading product, EmeTerm™, as a potential solution to motion sickness-induced vomiting. EmeTerm™'s innovative design and usability has received positive feedback from many other medical professionals at the event. EmeTerm™ is winner of iF Design Award 2017 with high level water-resist, magnetic recharging system, ergonomics design and medical level materials.
WAT Med remains in contact with NRC and are looking forward to offer solution for VR sickness and for other collaboration opportunities.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/emetermtm-offers-solution-to-vr-motion-sickness-300469380.html
SOURCE WAT Medical Enterprise Ltd.NEXT ARTICLE
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...